PET-MRI in Diagnosing Patients With Colon or Rectal Cancer

Summary

This pilot clinical trial studies positron emission tomography (PET)-magnetic resonance imaging (MRI) and PET-computed tomography (CT) as diagnostic imaging in patients with colon and/or rectal cancer. New diagnostic imaging procedures, such as PET-MRI, may help find and diagnose rectal cancer or recurrence of colorectal cancer

Conditions

• Recurrent Colon Cancer
• Recurrent Rectal Cancer
• Stage IIA Colon Cancer
• Stage IIA Rectal Cancer
• Stage IIB Colon Cancer
• Stage IIB Rectal Cancer
• Stage IIC Colon Cancer
• Stage IIC Rectal Cancer
• Stage IIIA Colon Cancer
• Stage IIIA Rectal Cancer
• Stage IIIB Colon Cancer
• Stage IIIB Rectal Cancer
• Stage IIIC Colon Cancer
• Stage IIIC Rectal Cancer
• Stage IVA Colon Cancer
• Stage IVA Rectal Cancer
• Stage IVB Colon Cancer
• Stage IVB Rectal Cancer

Interventions

PROCEDURE

positron emission tomography

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI

PROCEDURE

computed tomography

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI

PROCEDURE

magnetic resonance imaging

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI

RADIATION

fludeoxyglucose F 18

Undergo fludeoxyglucose F 18 PET-CT and PET-MRI

Sponsors & Collaborators

• Case Comprehensive Cancer Center

  lead OTHER

Principal Investigators

• Raj Paspulati, MD · Case Comprehensive Cancer Center

Study Design

Allocation

NA

Purpose

DIAGNOSTIC

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

22 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2013-04-30

Primary Completion

2014-03-05

Completion

2014-03-05

Countries

• United States

Study Locations